Literature DB >> 32087028

Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring.

Christine Biron-Andreani1,2, Isabelle Diaz-Cau2, Alexandre Ranc2, Robert Navarro1, Christian Leonardi3, Marion Dischino3, Romuald Guy4, Alexandre Theron1, Corinne Garcia-Gournay1,2, Elena Santagostino5, Jean-François Schved2.   

Abstract

Entities:  

Keywords:  emicizumab; haemophilia A; inhibitors; major surgery

Mesh：

Substances：

Year:  2020        PMID： 32087028     DOI： 10.1111/bjh.16512

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor.

Authors:  Charles R Lefèvre; Anaïs Jaffré; Adeline Pontis; Fabienne Nedelec-Gac; Pierre Guéret; Isabelle Gouin-Thibault; Bernard Fraisse; Sophie Bayart; Benoit Guillet
Journal:  TH Open       Date:  2021-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.